Gene · 57016
Papers1,760
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,760
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. | Int J Mol Sci | 2023 | 36901717 | PubTator, text mining | PubMed |
| Potential biomarker proteins for aspiration pneumonia detected by shotgun proteomics using buccal mucosa samples: a cross-sectional case-control study. | Clin Proteomics | 2023 | 36894881 | PubTator, text mining | PubMed |
| Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer. | Cell Mol Gastroenterol Hepatol | 2023 | 36893885 | PubTator, text mining | PubMed |
| Sulfotransferase 1C2 promotes hepatocellular carcinoma progression by enhancing glycolysis and fatty acid metabolism. | Cancer Med | 2023 | 36880364 | PubTator, text mining | PubMed |
| A Review of The Synergistic Effects of Curcumin with Proteasome Inhibitors in Multiple Myeloma Preclinical Models. | Integr Cancer Ther | 2023 | 36879488 | PubTator, text mining | PubMed |
| [Echinacoside hampers malignant progression of breast cancer MCF-7 cells by modulating AKR1B10/ERK signal transduction]. | Zhongguo Zhong Yao Za Zhi | 2023 | 36872238 | PubTator, text mining | PubMed |
| Systems-level multi-omics characterization provides novel molecular insights into indomethacin toxicity. | Chem Biol Interact | 2023 | 36868495 | PubTator, text mining | PubMed |
| A pan-cancer analysis shows immunoevasive characteristics in NRF2 hyperactive squamous malignancies. | Redox Biol | 2023 | 36867945 | PubTator, text mining | PubMed |
| Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. | Signal Transduct Target Ther | 2023 | 36864020 | PubTator, text mining | PubMed |
| Hyperinflammatory Response in COVID-19: A Systematic Review. | Viruses | 2023 | 36851766 | PubTator, text mining | PubMed |
New Insight into the Pharmacological Importance of Atropine as the Potential Inhibitor of AKR1B1 via Detailed Computational Investigations: DFTs, ADMET, Molecular Docking, and Molecular Dynamics Studies. | Appl Biochem Biotechnol | 2023 | 36847982 | PubTator, text mining | PubMed |
| FNDC5 and AKR1B10 inhibit the proliferation and metastasis of adrenocortical carcinoma cells by regulating AMPK/mTOR pathway. | Exp Ther Med | 2023 | 36845952 | PubTator, text mining | PubMed |
| Identification of AKR1B10 as a key gene in primary biliary cholangitis by integrated bioinformatics analysis and experimental validation. | Front Mol Biosci | 2023 | 36845547 | PubTator, text mining | PubMed |
| DKK3's protective role in prostate cancer is partly due to the modulation of immune-related pathways. | Front Immunol | 2023 | 36845147 | PubTator, text mining | PubMed |
| Molecular mechanisms of atrazine toxicity on H19-7 hippocampal neurons revealed by integrated miRNA and mRNA "omics". | Ecotoxicol Environ Saf | 2023 | 36841081 | PubTator, text mining | PubMed |
| In Vitro Tumor Models on Chip and Integrated Microphysiological Analysis Platform (MAP) for Life Sciences and High-Throughput Drug Screening. | Biosensors (Basel) | 2023 | 36831997 | PubTator, text mining | PubMed |
| Transcriptomic Analysis of Hepatitis B Infected Liver for Prediction of Hepatocellular Carcinoma. | Biology (Basel) | 2023 | 36829466 | PubTator, text mining | PubMed |
| Metabolic classifications of renal cell carcinoma reveal intrinsic connections with clinical and immune characteristics. | J Transl Med | 2023 | 36829161 | PubTator, text mining | PubMed |
| Expression of AKRs superfamily and prognostic in human gastric cancer. | Medicine (Baltimore) | 2023 | 36827074 | PubTator, text mining | PubMed |
| X or Y Cancer: An Extensive Analysis of Sex Differences in Lung Adenocarcinoma. | Curr Oncol | 2023 | 36826068 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57016/papers?page=15